GlassScriptPhysician profile
David Nolen
NPI 1427219278
$3,053.19
in general payments reported to CMS, 2019-2025
19 companies · $842 in 2025
The $842 reported for 2025 was more than what 82% of Facial Plastic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $336 · 2023: $845 · 2024: $1,029 · 2025: $842.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,385 · Long Term Medical Supply Or Device Loan: $306 · Education: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,385.22 |
| Long Term Medical Supply Or Device Loan | $305.80 |
| Education | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $795.78 | 2022-2025 | |
| Integra Lifesciences Corporation | $705.56 | 2024-2025 | Integra, Inspira Air, Acclarent Aera |
| Regeneron Healthcare Solutions, INC. | $332.79 | 2023-2025 | Dupixent |
| Inspire Medical Systems, INC. | $202.30 | 2022-2025 | Inspire |
| Olympus America INC. | $190.38 | 2023-2024 | Rhino-Laryngo Videoscope |
| Galderma Laboratories, L.P. | $100.69 | 2025 | Dysport |
| Abbvie INC. | $100.35 | 2023-2024 | |
| Medtronic, INC. | $95.59 | 2024 | Propel |
| Cochlear Americas | $91.90 | 2023 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Aerin Medical INC. | $69.81 | 2022-2024 | |
| Glaxosmithkline, LLC. | $63.88 | 2023-2024 | Nucala |
| Acclarent, INC | $53.93 | 2023 | Acclarent Aera, Trudi Nav Cable |
| Hill Dermaceuticals, INC. | $52.00 | 2022 | |
| Hikma Pharmaceuticals USA | $50.03 | 2024 | Ryaltris |
| Optinose US, INC. | $45.29 | 2023-2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $29.68 | 2023 | Restrata Wound Matrix |
| Avita Medical Americas, LLC | $28.66 | 2023 | Recell |
| Merck Sharp & Dohme LLC | $25.70 | 2025 | Keytruda |
| Stryker Corporation | $18.87 | 2024 | Scopis Ent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Nolen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.